Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
MIRA Pharmaceuticals, Inc. (MIRA) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.15M |
|
-- |
|
-- |
|
$1.10M |
|
$-1.10M |
|
$-0.05M |
|
$-1.15M |
|
$-1.15M |
|
$-1.15M |
|
$-1.15M |
|
$-1.15M |
|
$-1.15M |
|
$-1.10M |
|
$-1.10M |
|
41.94M |
|
41.94M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$9.43M |
|
-- |
|
$0.04M |
|
$9.46M |
|
$0.11M |
|
-- |
|
-- |
|
$0.11M |
|
$9.35M |
|
$9.35M |
|
$9.35M |
|
42.02M |
|
| Cash Flow Statement Financials | |
$-1.20M |
|
-- |
|
$-0.33M |
|
$6.35M |
|
$4.82M |
|
$-1.53M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
82.16 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.30% |
|
-12.30% |
|
-12.15% |
|
-12.30% |
|
$0.22 |
|
$-0.03 |
|
$-0.03 |
|